Cargando…
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
We report the safety and efficacy of autologous bone marrow transplantation (ABMT) in 30 patients with high-grade non-Hodgkin's lymphoma (NHL) in first complete remission (CR1) following remission induction chemotherapy. Two patients relapsed prior to ABMT. All patients were conditioned with hi...
Autores principales: | Jackson, G. H., Lennard, A. L., Taylor, P. R., Carey, P., Angus, B., Lucraft, H., Evans, R. G., Proctor, S. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033362/ https://www.ncbi.nlm.nih.gov/pubmed/7521662 |
Ejemplares similares
-
Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
por: Taylor, P. R., et al.
Publicado: (1993) -
Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents
por: Jones, G L, et al.
Publicado: (2007) -
Bone marrow examination in newly diagnosed Hodgkin's disease: current practice in the United Kingdom.
por: Howard, M. R., et al.
Publicado: (1995) -
Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994) -
A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.
por: Hayward, R. L., et al.
Publicado: (1991)